Benjamin Auld

Benjamin Auld

Auto-generated profile, based on publicly available information

Benjamin Auld

Queensland Paediatric Cardiac Service, Queensland Children’s Hospital, South Brisbane, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
JWJane M Wotherspoon
Jane M Wotherspoon
KEKaren J Eagleson
Karen J Eagleson
LGLinda Gilmore
Linda Gilmore
BABenjamin Auld
Benjamin Auld
AHAnne Hirst
Anne Hirst
RJRobert N Justo
Robert N Justo

1 April 2019 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
BABenjamin Auld
Benjamin Auld
LCLindsay Carrigan
Lindsay Carrigan
CWCameron Ward
Cameron Ward
RJRobert Justo
Robert Justo
NANelson Alphonso
Nelson Alphonso
BABen Anderson
Ben Anderson

11 November 2016 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
SRSteven Rathgeber
Steven Rathgeber
BABenjamin Auld
Benjamin Auld
SDStephanie Duncombe
Stephanie Duncombe
MHMartin C. K. Hosking
Martin C. K. Hosking
KHKevin C. Harris
Kevin C. Harris

1 November 2023 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
BABenjamin C. Auld
Benjamin C. Auld
BABridget Abell
Bridget Abell
PVPrem S. Venugopal
Prem S. Venugopal
SMSteven McPhail
Steven McPhail
Background: Geographical context is an important consideration for health system design to promote equality in access to care for patients with childhood heart disease (CHD), particularly those living in regional, rural, and remote areas. To help inform future policy and practice recommendations, this study aimed to (i) describe the geographic distribution of high-risk CHD patients accessing an Australian state-wide specialist service and (ii) estimate travel time for accessing healthcare via general practitioners (primary), nearest paediatric centre (secondary) and specialist paediatric cardiac centre (tertiary). Methods: Participants included a cohort of children (0–18 year) who accessed state-wide specialist CHD services over a 3-year period (2019–2021) in Queensland, Australia. Locations for patient residence, general practitioner, closest paediatric centre and tertiary cardiac centre were mapped using geographical information system (GIS) software (ArcGIS Online). Travel distance and times were estimated using a Google Maps Application Programming Interface (API). Results: 1019 patients (median age 3.8 years) had cardiac intervention and were included in the sample. Of this cohort, 30.2% lived outside the heavily urbanised South East Queensland (SEQ) area where the tertiary centre is located. These patients travel substantially further and longer to access tertiary level care (but not secondary or primary level care) compared to those in SEQ. Median distance for patients residing outside SEQ to access tertiary care was 953 km with a travel time of 10 h 43 min. This compares to 5.5 km to the general practitioner and 20.6 km to a paediatric service (8.9 and 54 min respectively). Conclusion: This geographical mapping of CHD services has demonstrated a key challenge inherent in providing specialist cardiac care to children in a large state-based healthcare system. A significant proportion of high-risk patients live large distances from tertiary level care. The greater accessibility of primary care services highlights the importance of supporting primary care physicians outside metropolitan areas to acquire or build the ability and capacity to care for children with CHD. Strengthening local primary and secondary services not only has the potential to improve the outcomes of high-risk patients, but also to reduce costs and burden associated with potentially avoidable travel from regional, rural, or remote areas to access specialist CHD services.

16 April 2021 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
BABenjamin C. Auld
Benjamin C. Auld
JDJulia S. Donald
Julia S. Donald
NLNaychi Lwin
Naychi Lwin
KBKim Betts
Kim Betts
NANelson O. Alphonso
Nelson O. Alphonso
BABenjamin W. Anderson
Benjamin W. Anderson
Background: Balloon valvuloplasty and surgical aortic valvotomy have been the treatment mainstays for congenital aortic stenosis in children. Choice of intervention often differs depending upon centre bias with limited relevant, comparative literature.Objectives: This study aims to provide an unbiased, contemporary matched comparison of these balloon and surgical approaches.Methods: Retrospective analysis of patients with congenital aortic valve stenosis who underwent balloon valvuloplasty (Queensland Children’s Hospital, Brisbane) or surgical valvotomy (Royal Children’s Hospital, Melbourne) between 2005 and 2016. Patients were excluded if pre-intervention assessment indicated ineligibility to either group. Propensity score matching was performed based on age, weight, and valve morphology.Results: Sixty-five balloon patients and seventy-seven surgical patients were included. Overall, the groups were well matched with 18 neonates/25 infants in the balloon group and 17 neonates/28 infants in the surgical group. Median age at balloon was 92 days (range 2 days – 18.8 years) compared to 167 days (range 0 days – 18.1 years) for surgery (rank-sum p = 0.08). Mean follow-up was 5.3 years. There was one late balloon death and two early surgical deaths due to left ventricular failure. There was no significant difference in freedom from reintervention at latest follow-up (69% in the balloon group and 70% in the surgical group, p = 1.0).Conclusions: Contemporary analysis of balloon aortic valvuloplasty and surgical aortic valvotomy shows no difference in overall reintervention rates in the medium term. Balloon valvuloplasty performs well across all age groups, achieving delay or avoidance of surgical intervention.

1 May 2011 in Pediatrics
Verified
Journal Article
Closed access
PDF file
BABenjamin Auld
Benjamin Auld
DUDonald Urquhart
Donald Urquhart
MWMark Walsh
Mark Walsh
CNClare Nourse
Clare Nourse
MHMargaret-Anne Harris
Margaret-Anne Harris
Deficiencies of the interferon γ (IFN-γ) pathway have become a well-recognized cause of nontuberculous mycobacterial infection. We report here a case of autosomal dominant IFN-γ receptor 1 (IFN-γ-R1) deficiency presenting at the unusually young age of 16 months with a severe clinical course. Mycobacterium avium complex was cultured from bronchial washings of a child who presented with primary endobronchial disease after a 4-month history of rhinorrhea, wheeze, and acute lobar consolidation. A maternal history of multifocal Mycobacterium kansasii osteomyelitis and cutaneous M avium complex led to genetic confirmation of IFN-γ-R1 818del4 deletion (a 4 base pair deletion at nucleotide position 818) in both family members. This case demonstrates the link between mycobacterial disease and IFN-γ pathway deficiency, the diagnosis of which facilitates more accurate therapy and genetic counseling. The case also raises questions about the reported distinct presentation, treatment, and prognosis of autosomal dominant and recessive IFN-γ-R1 phenotypes.